Calabrese EJ , Baldwin LA -2003-. Hormesis: The dose-response revolution. Annu Rev ToxicolPharmacol43: 175—193.
2.
Ashby J., Morrod RS -1991-. Detection of human carcinogens. Nature352: 185—186.
3.
Fung VA, Barrett JC, Huff J. - 1995-. The carcinogenesis bioassay in perspective: Application in identifying human cancer hazards. Environ Health Perspect103: 680—683.
4.
Enomoto M. -2000-. A search for chemical agents causing human cancer-Lessons learned from rodent carcinogenicity studies-. J Toxicol Sci25: 381— 392.
5.
Williams GM, Iatropoulos MJ, Jeffrey AM -2000-. Mechanistic basis fornonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine. Toxicol Pathol73: 394—402.
6.
O'Connor PJ, Manning FCR, Gordon AT et al -2000-. DNA repair: Kinetics and thresholds. Toxicol Pathol28: 375—381.
7.
Fukushima S. , Wanibuchi H., Morimura K., et al -2002-. Lack of a dose-response for carcinogenicity in the rat liver with low doses of 2-amino-3, 8-dimethylimidazo [4, 5- f ] quinoxaline or N-nitrosodiethylamine. Jpn J Cancer Res93: 1076—1082.
8.
Enomoto M. -1985-. How does Japan differentiate hyperplasia from neoplasia?Toxicol Pathol13: 110—118.
9.
Coggins CRE -1998-. A review of chronic inhalation studies with mainstream cigarette smoke in rats and mice. Toxicol Pathol26: 307—314.